Effectiveness of Canakinumab Treatment in Colchicine Resistant Familial Mediterranean Fever Cases

Anti-interleukin 1 agents are used successfully in colchicine-resistant or intolerant Familial Mediterranean Fever (FMF) patients. Sixty-five patients with FMF who received canakinumab treatment for at least 6 months due to colchicine resistance or intolerance between 2016 and 2020 in our department...

Descripción completa

Detalles Bibliográficos
Autores principales: Yücel, Burcu Bozkaya, Aydog, Ozlem, Nalcacioglu, Hulya, Yılmaz, Ayşegül
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461313/
https://www.ncbi.nlm.nih.gov/pubmed/34568239
http://dx.doi.org/10.3389/fped.2021.710501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461313/
https://www.ncbi.nlm.nih.gov/pubmed/34568239
http://dx.doi.org/10.3389/fped.2021.710501

Ejemplares similares